Literature DB >> 1443664

Cystogenesis of the ovarian antral follicle of the rat: ultrastructural changes and hormonal profile following the administration of dehydroepiandrosterone.

E Anderson1, M T Lee, G Y Lee.   

Abstract

Immature 27-day-old female Sprague-Dawley rats were administered daily subcutaneous injections of dehydroepiandrosterone (DHEA, 5 mg/100 g BW) to induce the formation of ovarian follicular cysts. Groups of rats were killed on days 0, 10, 15, 20, 25, and 30. Ovaries from each group of rats were processed for light and electron microscopy and for follicular or cystic fluid hormone analysis. Normal antral follicle fluid, PMSG-treated preovulatory follicular fluid, and cystic fluids were analyzed for progesterone (P), estrone (E1), estradiol (E2), testosterone (T), delta 4-androstenedione (delta 4-A), 5 alpha-dihydrotestosterone (DHT), luteinizing hormone (LH), follicle stimulating hormone (FSH), and prolactin (PRL). DHEA induced anovulation, acyclicity, and the formation of follicular cysts. In certain antral follicles, there was a dramatic increase in the quantities of smooth endoplasmic reticulum (SER) in the granulosa cells and many mitochondria had tubular cristae. Further depletion of granulosa cell number was associated with intense blebbing of the cytoplasm into the follicle antrum. Formation of the ovarian follicular cyst was completed when the entire cyst was lined by a single layer of transformed granulosa cells in contact via adhering, gap, and tight junctions. These cells had little cytoplasm, mitochondria with lamellar cristae, vast basal and apical bands of microfilaments, and an extensive array of smooth-surfaced endocytotic invaginations on the basal plasma membrane. These endocytotic pits may subsequently form smooth-surfaced vesicles and thereby serve as one mechanism for moving fluid from the ovarian interstitium into the cyst. Theca interna cells were rarely observed in the peripheral regions of the cyst. Abundant smooth muscle cells were located beneath the basement membrane of the epithelial cells comprising the cyst wall. These acquired morphological and physiological features may ensure persistence of the ovarian cyst and thus potentiate a chronic pathological condition. In this study it was also shown that progesterone, estrone, and estradiol as well as androgen concentration increased in the follicle after PMSG treatment. With DHEA treatment, the follicular cystic fluid concentrations of these steroids progressively increased to extremely high levels concurrent with the development of the follicular cysts.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1443664     DOI: 10.1002/ar.1092340307

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  12 in total

1.  Effect of Vitamin D3 on Mitochondrial Biogenesis in Granulosa Cells Derived from Polycystic Ovary Syndrome.

Authors:  Zahra Safaei; S Habnam Bakhshalizadeh; Mohammad Hossein Nasr Esfahani; Azadeh Akbari Sene; Vahid Najafzadeh; Mansoureh Soleimani; Reza Shirazi
Journal:  Int J Fertil Steril       Date:  2020-07-15

Review 2.  Significance of matrix metalloproteinases in the pathophysiology of the ovary and uterus.

Authors:  Toshiaki Endo; Tamotsu Kiya; Taeko Goto; Hirofumi Henmi; Kengo Manase; Hiroyuki Honnma; Tsuyoshi Baba; Shinichi Ishioka; Takuhiro Hayashi; Manabu Chida; Kazuyo Arima; Kiyohiro Yamazaki; Mika Kanaya; Atsushi Azumaguchi; Osamu Moriwaka; Hirofumi Kamiya; Tsuyoshi Saito
Journal:  Reprod Med Biol       Date:  2006-11-23

3.  A giant ovarian cyst in a neonate with classical 21-hydroxylase deficiency with very high testosterone levels demonstrating a high-dose hook effect.

Authors:  Tülay Güran; Gözde Yeşil; Ömer Güran; Suna Cesur; Oktav Bosnalı; Ayşenur Celayir; Sevilay Topçuoğlu; Abdullah Bereket
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-05-02

4.  Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.

Authors:  Irene Tessaro; Silvia C Modina; Federica Franciosi; Giulia Sivelli; Laura Terzaghi; Valentina Lodde; Alberto M Luciano
Journal:  J Ovarian Res       Date:  2015-10-06       Impact factor: 4.234

5.  Ultra-low Doses of Follicle Stimulating Hormone and Progesterone Attenuate the Severity of Polycystic Ovary Syndrome Features in a Hyperandrogenized Mouse Model.

Authors:  Irene Tessaro; Silvia Modina; Valentina Lodde; Giulia Sivelli; Federica Franciosi; Laura Terzaghi; Patrizia Luchini; Cristiano Rumio; Alberto Maria Luciano
Journal:  J Reprod Infertil       Date:  2017 Jul-Sep

6.  The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS).

Authors:  Aylin Yaba; Necdet Demir
Journal:  J Ovarian Res       Date:  2012-11-27       Impact factor: 4.234

7.  Modulation of Cx43 and Gap Junctional Intercellular Communication by Androstenedione in Rat Polycystic Ovary and Granulosa Cells in vitro.

Authors:  Rabih Talhouk; Charbel Tarraf; Laila Kobrossy; Abdallah Shaito; Samer Bazzi; Dana Bazzoun; Marwan El-Sabban
Journal:  J Reprod Infertil       Date:  2012-01

8.  Expression and activity of Rac1 is negatively affected in the dehydroepiandrosterone induced polycystic ovary of mouse.

Authors:  Vineet Kumar Maurya; Chadchan Sangappa; Vijay Kumar; Sahil Mahfooz; Archana Singh; Singh Rajender; Rajesh Kumar Jha
Journal:  J Ovarian Res       Date:  2014-03-14       Impact factor: 4.234

9.  The effect of androgens on ovarian follicle maturation: Dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPARγ-dependent PTEN expression.

Authors:  Mei-Jou Chen; Chia-Hung Chou; Shee-Uan Chen; Wei-Shiung Yang; Yu-Shih Yang; Hong-Nerng Ho
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

10.  Electroacupuncture alleviates polycystic ovary syndrome-like symptoms through improving insulin resistance, mitochondrial dysfunction, and endoplasmic reticulum stress via enhancing autophagy in rats.

Authors:  Yan Peng; Liyuan Guo; Anxin Gu; Beibei Shi; Yukun Ren; Jing Cong; Xinming Yang
Journal:  Mol Med       Date:  2020-07-22       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.